Free Trial

Medifast (MED) Earnings Date, Estimates & Call Transcripts

Medifast logo
$18.89 +0.30 (+1.61%)
(As of 09:32 AM ET)

Medifast Latest Earnings Summary

Actual EPS
(Nov. 4)
$0.35 Beat By $0.50
Consensus EPS
(Nov. 4)
-$0.15

Medifast announced Q3 2024 earnings on November 4, 2024, reporting an EPS of $0.35, which topped the consensus estimate of -$0.15 by $0.50. Quarterly revenue was reported to be $140.16 million, above analysts' expectations of $135.45 million. With a trailing EPS of $0.66 and a P/E Ratio of 28.17, Medifast's earnings are expected to decrease -69.64% next year, from $1.68 to $0.51 per share.

Get Medifast Earnings Alerts

Want to stay updated on the latest earnings announcements and upcoming reports? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Medifast and other key companies, straight to your inbox.

Sign Up
Skip Charts & View Estimated and Actual Earnings Data

MED Earnings Estimates and Actuals by Quarter

The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.

MED Estimated and Actual Revenue by Quarter

The chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter.

Medifast Analyst EPS Estimates

QuarterNumber of EstimatesLow EstimateHigh EstimateAverage EstimateCompany Guidance
Q1 20242$0.82$1.72$1.270.250 - 0.950
Q2 20242$0.32$0.40$0.360.050 - 0.400
Q3 20242-$0.15$0.13-$0.01 - 0.700 - - 0.050
Q4 20242-$0.43-$0.10-$0.270.100 - 0.650
FY 20248$0.56$2.15$1.36 
Q1 20251-$0.10-$0.10-$0.10 
Q2 20251$0.29$0.29$0.29 
Q3 20251$0.34$0.34$0.34 
Q4 20251$0.38$0.38$0.38 
FY 20254$0.91$0.91$0.91 
Q1 20261$0.42$0.42$0.42 
Q2 20261$0.43$0.43$0.43 
Q3 20261$0.38$0.38$0.38 

Medifast Earnings History by Quarter

DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueDetails
11/4/2024Q3 2024-$0.15$0.35+$0.50$0.60$135.45M$140.16M
8/5/2024Q2 2024$0.36$0.92+$0.56$2.59$160.44M$168.56M
4/29/2024Q1 2024$0.78$0.66 -$0.12$0.56$168.90M$174.74M
2/20/2024Q4 2023$0.99$1.09+$0.10$1.63$184.17M$191.02M
11/6/2023Q3 2023$1.02$2.12+$1.10$2.12$232.10M$235.87M
8/7/2023Q2 2023$1.44$2.77+$1.33$2.77$270.20M$296.20M
5/1/2023Q1 2023$2.40$3.67+$1.27$3.67$319.50M$349.00M
2/21/2023Q4 2022$2.18$3.70+$1.52$4.99$306.70M$337.25M

Medifast Earnings - Frequently Asked Questions

Medifast (NYSE:MED) last announced its quarterly earning data on Monday, November 4, 2024. Learn more on MED's earnings history.

Medifast updated its fourth quarter 2024 earnings guidance on Monday, November, 4th. The company provided EPS guidance of 0.100-0.650 for the period, compared to the consensus earnings per share estimate of -0.180. The company issued revenue guidance of $100.0 million-$120.0 million, compared to the consensus revenue estimate of $130.0 million.

In the previous quarter, Medifast (NYSE:MED) reported $0.35 earnings per share (EPS) to beat the analysts' consensus estimate of ($0.15) by $0.50. Learn more on analysts' earnings estimate vs. MED's actual earnings.

The conference call for Medifast's latest earnings report can be listened to online.
Listen to Conference Call

The conference call transcript for Medifast's latest earnings report can be read online.
Read Transcript

Medifast (NYSE:MED) has a recorded annual revenue of $674.48 million.

Medifast (NYSE:MED) has a recorded net income of $99.42 million. MED has generated $0.66 earnings per share over the last four quarters.

Medifast (NYSE:MED) has a trailing price-to-earnings ratio of 28.17 and a forward price-to-earnings ratio of 11.07.

Medifast's earnings are expected to decrease from $1.68 per share to $0.51 per share in the next year, which is a -69.64% change.

More Earnings Resources from MarketBeat



This page (NYSE:MED) was last updated on 12/18/2024 by MarketBeat.com Staff
From Our Partners